PSMD4P1: A Drug Target / Disease Biomarker (G54035)

Target Name: PSMD4P1

NCBI ID: G54035

Other Name(s): proteasome 26S subunit, non-ATPase 4 pseudogene 1 | PSMD4P | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 pseudogene 1 | PSMD15

PSMD4P1: A Drug Target / Disease Biomarker

PSMD4P1 is a protein that is expressed in the brain and is known for its role in the regulation of pain signaling. It is a potential drug target for several diseases, including chronic pain and neurodegenerative disorders.

The discovery of PSMD4P1 was made through a combination of biochemical, cellular, and animal studies. Researchers found that PSMD4P1 was expressed in the brain and that it was involved in the regulation of pain signaling. They also found that inhibiting PSMD4P1 reduced pain sensitivity in animals.

These findings suggest that PSMD4P1 could be a useful drug target for chronic pain and neurodegenerative disorders. By blocking the activity of PSMD4P1, researchers hope to be able to treat these conditions and improve the quality of life for people.

In addition to its potential as a drug target, PSMD4P1 has also been identified as a potential biomarker for several neurodegenerative disorders. The fact that it is expressed in the brain and is involved in the regulation of pain signaling suggests that it may be a useful indicator of the severity and progression of these disorders.

PSMD4P1 is also of interest as a potential therapeutic target for other conditions that involve the regulation of pain signaling. For example, it is possible that PSMD4P1 could be used to treat chronic pain caused by conditions such as cancer, neuropathy, and rheumatoid arthritis.

The identification of PSMD4P1 as a potential drug target and biomarker for several neurodegenerative disorders has the potential to lead to new treatments for these conditions. By blocking the activity of PSMD4P1, researchers hope to be able to improve the quality of life for people and slow the progression of these disorders.

In conclusion, PSMD4P1 is a protein that has the potential to be a drug target and biomarker for several neurodegenerative disorders. Its expression in the brain and its involvement in the regulation of pain signaling make it an attractive target for researchers to study and develop new treatments. Further studies are needed to fully understand its potential and to determine its effectiveness as a drug.

Protein Name: Proteasome 26S Subunit, Non-ATPase 4 Pseudogene 1

More Common Targets